12109297 · Active · incorporated 7 years, 3 months ago · Oxford
Biotech Deep Tech Drug Discovery Healthcare Platform Series B+
Nucleome Therapeutics decodes the non-coding human genome to discover new ways to treat diseases.
Nucleome is a private limited company registered at Companies House under number 12109297, incorporated on 17 July 2019, with a registered office in Oxford. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 88 filings for this company, including 3 funding rounds. Its most recent round closed in July 2024, raising £18.8m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 3 | Jul 2024 | £18.8m | £0.01 |
| Round 2 | Nov 2022 | £18.8m | £1.04 |
| Round 1 | Aug 2019 | £5.2m | £1.00 |
Showing the 10 most recent of 88 filings.
See the complete cap table with every shareholder, founder tags, dilution across 29 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.